PROLEUKIN Side Effects

6959521-X | Acute Febrile Neutrophilic Dermatosis, Fatigue, Injection Site Mass, Post Inflammatory Pigmentation Change, Pseudolymphoma, Skin Exfoliation, Skin Oedema
on Aug 13, 2010 Male patient from UNITED STATES , 46 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Proleukin (View Usage). Patient experienced the following unwanted or unexpected effects: acute febrile neutrophilic dermatosis, fatigue, injection site mass, post inflammatory pigmentation change, pseudolymphoma, skin exfoliation, skin oedema. Proleukin dosage: 7.5 Miou; X5 Days Every 2 Months; Sc. During the same period patient was treated with DIDANOSINE (View Didanosine Review and Didanosine Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), PROCHLORPERAZINE MALEATE (View Prochlorperazine Maleate Review and Prochlorperazine Maleate Label ), PSEUDOEPHEDRINE HYDROCHLORIDE (View Pseudoephedrine Hydrochloride Review and Pseudoephedrine Hydrochloride Label ).

6940055-3 | Acute Febrile Neutrophilic Dermatosis, Blister, Dermatitis Bullous, Erythema, Fatigue, Injection Site Erythema, Leukocytoclastic Vasculitis, Nodule, Pallor
Patient was taking Proleukin (View Usage). Patient had the following side effects: acute febrile neutrophilic dermatosis, blister, dermatitis bullous, erythema, fatigue, injection site erythema, leukocytoclastic vasculitis, nodule, pallor on Aug 13, 2010 from UNITED STATES Additional patient health information: Male patient , 46 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Proleukin dosage: 7.5 Miou For 5 Days Every 2 Month.

6786778-0 | Haemodynamic Instability, Pyrexia, Renal Failure
Adverse event was reported on Jun 16, 2010 by a Female patient taking Proleukin (View Usage) (Dosage: 3.5?10^5 Iu Q12h) . Location: UNITED STATES , 48 years of age, After Proleukin was administered, patient had the following side effects: haemodynamic instability, pyrexia, renal failure. During the same period patient was treated with FOSCARNET (View Foscarnet Review and Foscarnet Label ), CIDOFOVIR (View Cidofovir Review and Cidofovir Label ).

6595923-1 | Abdominal Distension, Abdominal Pain, Injection Site Erythema, Injection Site Pain
on Feb 02, 2010 Male patient from UNITED STATES , 69 years of age, was diagnosed with colon cancer and was treated with Proleukin (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, abdominal pain (What is abdominal pain?), injection site erythema, injection site pain. Proleukin dosage: 22 Miu;qw;sc. During the same period patient was treated with TARCEVA (View Tarceva Review and Tarceva Label ), XELODA (View Xeloda Review and Xeloda Label ), ZOFRAN (View Zofran Review and Zofran Label ), 5 FU (View 5-fu Review and 5-fu Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ). Patient was hospitalized.


6553743-8 | Necrosis, Pain In Extremity, Peripheral Coldness, Peripheral Ischaemia, Skin Discolouration, Skin Lesion, Skin Ulcer, Tenderness
on Jan 14, 2010 Male patient from SPAIN , 39 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Proleukin (View Usage). Patient had the following side effects: necrosis, pain in extremity, peripheral coldness, peripheral ischaemia, skin discolouration, skin lesion, skin ulcer, tenderness. Proleukin dosage: 4.5 Miu, Bid For 5 Days Every Two Months. During the same period patient was treated with TENOFOVIR (View Tenofovir Review and Tenofovir Label ), LOPINAVIR AND RITONAVIR (View Lopinavir And Ritonavir Review and Lopinavir And Ritonavir Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ). Patient was hospitalized.

6536656-7 | Lymphopenia
Patient was taking Proleukin (View Usage). After Proleukin was administered, patient had the following side effects: lymphopenia on Jun 25, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 197.1 lb, was diagnosed with malignant melanoma and. Proleukin dosage: 600000 Iu/kg, Q8h. During the same period patient was treated with RAF265A RAF+ (30 Mg) (View Raf265a Raf+ Review and Raf265a Raf+ Label ).

6506208-3 | Abdominal Pain, Blood Bilirubin Increased, Clostridium Difficile Colitis, Diarrhoea, Febrile Neutropenia, Neutropenic Sepsis, Pyrexia, Thrombocytopenia
Adverse event was reported on Dec 07, 2009 by a Female patient taking Proleukin (View Usage) (Dosage: Unk) was diagnosed with pancreatic carcinoma metastatic and. Location: SWEDEN , 40 years of age, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), blood bilirubin increased, clostridium difficile colitis, diarrhoea, febrile neutropenia, neutropenic sepsis, pyrexia, thrombocytopenia. During the same period patient was treated with CYCLOPHOSPHAMIDE (Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), FLUDARABINE (Unk) (View Fludarabine Review and Fludarabine Label ), MEROPENEM (Unk) (View Meropenem Review and Meropenem Label ), TEICOPLANIN (Unk) (View Teicoplanin Review and Teicoplanin Label ). Patient was hospitalized.

6369033-2 | Inflammation, Skin Ulcer
on Sep 08, 2009 Male patient from GERMANY , 71 years of age, was diagnosed with metastases to skin and was treated with Proleukin (View Usage). Patient had the following side effects: inflammation, skin ulcer. Proleukin dosage: Unk. During the same period patient was treated with DIPHENYLCYCLOPROPENONE (Unk) (View Diphenylcyclopropenone Review and Diphenylcyclopropenone Label ), DACARBAZINE (Unk) (View Dacarbazine Review and Dacarbazine Label ).

6326131-7 | Graft Versus Host Disease, Hepatitis Acute
on Aug 18, 2009 Male patient from KOREA, REPUBLIC OF , 48 years of age, was diagnosed with acute myeloid leukaemia and was treated with Proleukin (View Usage). After Proleukin was administered, patient had the following side effects: graft versus host disease, hepatitis acute. Proleukin dosage: . During the same period patient was treated with WILMS TUMOUR GENE 1 SPECIFIC CYTOTOXIC T LYMPHOCYTES (2x10^7/m^2) (View Wilms Tumour Gene 1-specific Cytotoxic T-lymphocytes Review and Wilms Tumour Gene 1-specific Cytotoxic T-lymphocytes Label ).

6303454-9 | Blood Uric Acid Abnormal, Deep Vein Thrombosis, Fatigue, Hyperbilirubinaemia
Patient was taking Proleukin (View Usage). Patient experienced the following unwanted or unexpected effects: blood uric acid abnormal, deep vein thrombosis (What is deep vein thrombosis?), fatigue, hyperbilirubinaemia on Jul 28, 2009 from UNITED STATES Additional patient health information: Male patient , 47 years of age, was diagnosed with metastatic renal cell carcinoma and. Proleukin dosage: 18 X10^6 Iu/m^2 Continuous Infusion For 120 Hours, Days 1 And 14, And Three Maintenance Cycle Weeks. During the same period patient was treated with INTERFERON ALFA 2A (6 Miu Every Other Day) (View Interferon Alfa-2a Review and Interferon Alfa-2a Label ), VACCINES (1 ? 10^7 Cells/1 Ml Lactated Ringer's Solution) (View Vaccines Review and Vaccines Label ).

6301653-3 | Dehydration, Metabolic Disorder, Myalgia, Pruritus
Adverse event was reported on Jul 28, 2009 by a Female patient taking Proleukin (View Usage) (Dosage: 18 X10^6 Iu/m^2 Continuous Infusion For 120 Hours, Days 1 And 14, And Three Maintenance Cycle Weeks) was diagnosed with metastatic renal cell carcinoma and. Location: UNITED STATES , 50 years of age, Patient had the following side effects: dehydration, metabolic disorder (What is metabolic disorder?), myalgia, pruritus. During the same period patient was treated with INTERFERON ALFA 2A (6 Miu Every Other Day) (View Interferon Alfa-2a Review and Interferon Alfa-2a Label ), VACCINES (1 ? 10^7 Cells/1 Ml Lactated Ringer's Solution) (View Vaccines Review and Vaccines Label ), SUNITINIB MALATE (View Sunitinib Malate Review and Sunitinib Malate Label ), SORAFENIB (View Sorafenib Review and Sorafenib Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ).

6301652-1 | Activated Partial Thromboplastin Time Abnormal, Blood Creatinine Abnormal, Hypocalcaemia, Hypotension, Hypoxia, International Normalised Ratio Abnormal, Pruritus, Rash
on Jul 28, 2009 Male patient from UNITED STATES , 76 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Proleukin (View Usage). After Proleukin was administered, patient had the following side effects: activated partial thromboplastin time abnormal, blood creatinine abnormal, hypocalcaemia, hypotension, hypoxia, international normalised ratio abnormal, pruritus, rash (What is rash?). Proleukin dosage: 18 X10^6 Iu/m^2 Continuous Infusion For 120 Hours, On Days 1 And 14. During the same period patient was treated with INTERFERON ALFA 2A (6 Miu Every Other Day) (View Interferon Alfa-2a Review and Interferon Alfa-2a Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ).

6301651-X | Bundle Branch Block Right, Cardiomyopathy, Dermatitis, Hyperglycaemia, Hypophosphataemia, Nausea, Nephritis, Oedema, Pulmonary Embolism
on Jul 28, 2009 Male patient from UNITED STATES , 64 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Proleukin (View Usage). Patient experienced the following unwanted or unexpected effects: bundle branch block right, cardiomyopathy (What is cardiomyopathy?), dermatitis, hyperglycaemia, hypophosphataemia, nausea (What is nausea?), nephritis, oedema, pulmonary embolism (What is pulmonary embolism?). Proleukin dosage: 18 X10^6 Iu/m^2 Continuous Infusion For 120 Hours, Days 1 And 14, And Three Maintenance Cycle Weeks. During the same period patient was treated with INTERFERON ALFA 2A (6 Miu Every Other Day) (View Interferon Alfa-2a Review and Interferon Alfa-2a Label ), VACCINES (1 ? 10^7 Cells/1 Ml Lactated Ringer's Solution) (View Vaccines Review and Vaccines Label ).

6268446-7 | Disease Recurrence, Hypotension, Hypoxia, Pleural Effusion, Renal Failure Acute
Patient was taking Proleukin (View Usage). Patient had the following side effects: disease recurrence, hypotension, hypoxia, pleural effusion, renal failure acute on Jul 09, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 135.4 lb, was diagnosed with renal cancer metastatic and. Proleukin dosage: 37.0 Miu Q 8 Hrs Iv Bolus.

6247145-1 | Fatigue, Hypoglycaemia, Hypotension, Pyrexia
Adverse event was reported on Jun 24, 2009 by a Male patient taking Proleukin (View Usage) (Dosage: 88.2 Miu Every 8 Hours Iv Bolus) was diagnosed with renal cancer metastatic and. Location: UNITED STATES , weighting 324.1 lb, After Proleukin was administered, patient had the following side effects: fatigue, hypoglycaemia, hypotension, pyrexia.

6242487-8 | Blood Pressure Systolic Increased, Capillary Leak Syndrome, Chills, Heart Rate Increased, Hypotension, Malignant Pleural Effusion, Respiratory Distress, Respiratory Failure, Sinus Tachycardia
on Jun 22, 2009 Male patient from UNITED STATES , weighting 141.1 lb, was diagnosed with renal cancer metastatic and was treated with Proleukin (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure systolic increased, capillary leak syndrome, chills, heart rate increased, hypotension, malignant pleural effusion, respiratory distress, respiratory failure, sinus tachycardia. Proleukin dosage: 38.8 Miu Every 8 Hours Iv Bolus.

6216600-2 | Achromotrichia Acquired, Alopecia, Anterior Chamber Cell, Blood Creatinine Increased, Cataract Operation, Deafness, Eye Pain, Insomnia, Intraocular Lens Implant
on May 25, 2009 Male patient from UNITED STATES , 35 years of age, was diagnosed with metastatic malignant melanoma and was treated with Proleukin (View Usage). Patient had the following side effects: achromotrichia acquired, alopecia, anterior chamber cell, blood creatinine increased, cataract operation, deafness, eye pain, insomnia, intraocular lens implant. Proleukin dosage: Unk. During the same period patient was treated with CYCLOPHOSPHAMIDE (60 Mg/kg For 2 Days) (View Cyclophosphamide Review and Cyclophosphamide Label ), FLUDARABINE PHOSPHATE (25 Mg/m2) (View Fludarabine Phosphate Review and Fludarabine Phosphate Label ).

6208985-8 | Capillary Leak Syndrome, Condition Aggravated, Cytomegalovirus Chorioretinitis, Hypotension, Multi-organ Failure, Rectal Haemorrhage, Renal Failure, Respiratory Failure, Viral Load Increased
Patient was taking Proleukin (View Usage). After Proleukin was administered, patient had the following side effects: capillary leak syndrome, condition aggravated, cytomegalovirus chorioretinitis, hypotension, multi-organ failure, rectal haemorrhage, renal failure, respiratory failure, viral load increased on May 15, 2009 from SPAIN Additional patient health information: Male patient , 14 years of age, . Proleukin dosage: 4 Mu/m^2 Given Twice Daily In 5-day Courses Every 8 Weeks For 6 Cycles. During the same period patient was treated with GANCICLOVIR (View Ganciclovir Review and Ganciclovir Label ), FOSCARNET (View Foscarnet Review and Foscarnet Label ). Patient was hospitalized.

6082701-5 | Asthenia, Blood Creatinine Increased, Diarrhoea, Hyponatraemia
Adverse event was reported on Feb 10, 2009 by a Female patient taking Proleukin (View Usage) (Dosage: ) was diagnosed with renal cancer and. Location: FRANCE , 16 years of age, Patient experienced the following unwanted or unexpected effects: asthenia, blood creatinine increased, diarrhoea, hyponatraemia. Patient was hospitalized.

6023520-5 | Arthralgia, Erythema, Gastrointestinal Haemorrhage, Gingival Bleeding, Malaise, Oedema Peripheral, Petechiae
on Dec 17, 2008 Male patient from UNITED STATES , 50 years of age, was diagnosed with renal cell carcinoma and was treated with Proleukin (View Usage). Patient had the following side effects: arthralgia, erythema, gastrointestinal haemorrhage, gingival bleeding, malaise, oedema peripheral, petechiae. Proleukin dosage: 600000 Iu/kg, Q8h.

5982608-5 | Activated Partial Thromboplastin Time Shortened, Coagulation Factor Decreased, Disseminated Intravascular Coagulation, Hypotension, Prothrombin Level Decreased, Thrombocytopenia
on Nov 28, 2008 Male patient from FRANCE , 73 years of age, was diagnosed with gastric cancer stage iv, metastasis and was treated with Proleukin (View Usage). After Proleukin was administered, patient had the following side effects: activated partial thromboplastin time shortened, coagulation factor decreased, disseminated intravascular coagulation, hypotension, prothrombin level decreased, thrombocytopenia. Proleukin dosage: . During the same period patient was treated with INNACELL (View Innacell Review and Innacell Label ).

5962064-3 | Anaphylactic Reaction, Blood Pressure Decreased, Diarrhoea, Influenza Like Illness, Nausea, Surgery, Urticaria
Patient was taking Proleukin (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction, blood pressure decreased, diarrhoea, influenza like illness, nausea (What is nausea?), surgery (What is surgery?), urticaria on Nov 12, 2008 from GERMANY Additional patient health information: Male patient , 39 years of age, was diagnosed with metastasis and. Proleukin dosage: 3 X 6 Million Iu/ Week. During the same period patient was treated with INTERFERON ALFA (View Interferon Alfa Review and Interferon Alfa Label ).

5930494-1 | Overdose
Adverse event was reported on Sep 24, 2008 by a Male patient taking Proleukin (View Usage) (Dosage: ) . Location: CANADA , child 4 years of age, Patient had the following side effects: overdose.

5867355-2 | Blood Creatinine Increased, Body Temperature Increased, Bundle Branch Block Left, Flushing, Hypotension, Malaise, Nausea, Sinus Tachycardia
on Aug 21, 2008 Male patient from UNITED STATES , 50 years of age, was diagnosed with nausea (What is nausea?), pyrexia and was treated with Proleukin (View Usage). After Proleukin was administered, patient had the following side effects: blood creatinine increased, body temperature increased, bundle branch block left, flushing, hypotension, malaise, nausea (What is nausea?), sinus tachycardia. Proleukin dosage: 600,000 Iu/kg/dose. During the same period patient was treated with MOXIFLOXACIN HCL (400 Mg Daily) (View Moxifloxacin Hcl Review and Moxifloxacin Hcl Label ), METOPROLOL TARTRATE (50 Mg, Bid) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), AMLODIPINE (10 Mg, Qd) (View Amlodipine Review and Amlodipine Label ), LEVOTHYROXINE (25 Ug, Qd) (View Levothyroxine Review and Levothyroxine Label ), AMIODARONE (200 Mg, Qd) (View Amiodarone Review and Amiodarone Label ), DOLASETRON (100 Mg) (View Dolasetron Review and Dolasetron Label ), RANITIDINE (150 Mg, Bid) (View Ranitidine Review and Ranitidine Label ), ACETAMINOPHEN (650 Mg, Q4h) (View Acetaminophen Review and Acetaminophen Label ).

5839770-4 | Anorexia, Malignant Neoplasm Progression, Nausea, Weight Decreased
on Aug 05, 2008 Male patient from UNITED STATES , weighting 224.9 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Proleukin (View Usage). Patient experienced the following unwanted or unexpected effects: anorexia, malignant neoplasm progression, nausea (What is nausea?), weight decreased. Proleukin dosage: 7 Mu/m2 5 Days A Week, 3 Of Every 4 Weeks. During the same period patient was treated with ZOLEDRONIC ACID (4 Mg, Every 4 Weeks) (View Zoledronic Acid Review and Zoledronic Acid Label ).

5828996-1 | Anorexia, Malignant Neoplasm Progression, Nausea, Weight Decreased
Patient was taking Proleukin (View Usage). Patient had the following side effects: anorexia, malignant neoplasm progression, nausea (What is nausea?), weight decreased on Jul 22, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 224.9 lb, was diagnosed with metastatic renal cell carcinoma and. Proleukin dosage: 7 Mu/m2 5 Days A Week, 3 Of Every 4 Weeks. During the same period patient was treated with ZOLEDRONIC ACID (4 Mg, Every 4 Weeks) (View Zoledronic Acid Review and Zoledronic Acid Label ).

5804048-1 | Eosinophilia, Hypotension, White Blood Cell Count Increased
Adverse event was reported on Oct 17, 2007 by a Male patient taking Proleukin (View Usage) (Dosage: ) was diagnosed with metastatic malignant melanoma and. Location: UNITED STATES , 45 years of age, After Proleukin was administered, patient had the following side effects: eosinophilia, hypotension, white blood cell count increased.

5750306-9 | Acidosis, Acute Respiratory Distress Syndrome, Anoxic Encephalopathy, Atrial Fibrillation, Blood Pressure Systolic Decreased, Cardio-respiratory Arrest, Circulatory Collapse, Heart Rate Irregular, Pupillary Reflex Impaired
on May 21, 2008 Male patient from UNITED STATES , 70 years of age, weighting 314.2 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Proleukin (View Usage). Patient experienced the following unwanted or unexpected effects: acidosis, acute respiratory distress syndrome, anoxic encephalopathy, atrial fibrillation (What is atrial fibrillation?), blood pressure systolic decreased, cardio-respiratory arrest, circulatory collapse, heart rate irregular, pupillary reflex impaired. Proleukin dosage: 600,000 Iu/kg Chiron Q8h Iv Bolus. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), CEPHALEXIN (View Cephalexin Review and Cephalexin Label ), IBUROFEN (View Iburofen Review and Iburofen Label ), HYDROXYZINE (View Hydroxyzine Review and Hydroxyzine Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), LOPERAMIDE HCL (View Loperamide Hcl Review and Loperamide Hcl Label ), PROCHLORPERAZINE (View Prochlorperazine Review and Prochlorperazine Label ). Patient was hospitalized.

5743019-0 | Anorexia, Capillary Leak Syndrome, Constipation, Diarrhoea, Gait Disturbance, Renal Failure Acute, Weight Decreased
on May 15, 2008 Female patient from UNITED STATES , 71 years of age, weighting 141.0 lb, was diagnosed with metastatic malignant melanoma and was treated with Proleukin (View Usage). Patient had the following side effects: anorexia, capillary leak syndrome, constipation (What is constipation?), diarrhoea, gait disturbance, renal failure acute, weight decreased. Proleukin dosage: . Patient was hospitalized.

5716098-4 | Alanine Aminotransferase Increased, Anxiety, Aspartate Aminotransferase Increased, Hallucination, Visual, Hypoxia, Polyuria, Tachycardia, Urine Output Increased
Patient was taking Proleukin (View Usage). After Proleukin was administered, patient had the following side effects: alanine aminotransferase increased, anxiety (What is anxiety?), aspartate aminotransferase increased, hallucination, visual, hypoxia, polyuria, tachycardia, urine output increased on Apr 23, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 154.9 lb, . Proleukin dosage: .

5716097-2 | Blood Bicarbonate Decreased, Blood Creatinine Increased, Hypotension, Oliguria
Adverse event was reported on Apr 23, 2008 by a Male patient taking Proleukin (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 163.3 lb, Patient experienced the following unwanted or unexpected effects: blood bicarbonate decreased, blood creatinine increased, hypotension, oliguria.

5708985-8 | Electrolyte Imbalance, Fluid Retention, Mucosal Inflammation, Oliguria, Pharyngolaryngeal Pain, Scrotal Swelling
on Apr 14, 2008 Male patient from UNITED STATES , weighting 170.4 lb, was treated with Proleukin (View Usage). Patient had the following side effects: electrolyte imbalance, fluid retention, mucosal inflammation, oliguria, pharyngolaryngeal pain, scrotal swelling. Proleukin dosage: . Patient was hospitalized.

5677283-3 | Anuria, Blood Creatinine Increased, Diarrhoea, Fluid Retention, Hypotension, Metabolic Encephalopathy, Mucosal Inflammation, Nausea, Pain
on Mar 20, 2008 Male patient from UNITED STATES , weighting 115.1 lb, was treated with Proleukin (View Usage). After Proleukin was administered, patient had the following side effects: anuria, blood creatinine increased, diarrhoea, fluid retention, hypotension, metabolic encephalopathy, mucosal inflammation, nausea (What is nausea?), pain (What is pain?). Proleukin dosage: .

5626073-6 | Chills, Diarrhoea, Eye Swelling, Pharyngeal Oedema, Rash Erythematous, Rash Pruritic, Tachycardia
Patient was taking Proleukin (View Usage). Patient experienced the following unwanted or unexpected effects: chills, diarrhoea, eye swelling, pharyngeal oedema, rash erythematous, rash pruritic, tachycardia on Feb 13, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 181.4 lb, . Proleukin dosage: .

5604069-8 | Atrial Fibrillation, Palpitations, Renal Impairment, Supraventricular Tachycardia, Vomiting
Adverse event was reported on Jan 23, 2008 by a Female patient taking Proleukin (View Usage) (Dosage: ) was diagnosed with metastatic malignant melanoma and. Location: UNITED STATES , weighting 207.4 lb, Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), palpitations, renal impairment, supraventricular tachycardia, vomiting.

5589440-5 | Haemophilus Sepsis, Pain, Thrombocytopenia
on Jan 08, 2008 Male patient from UNITED STATES , 34 years of age, weighting 176.8 lb, was diagnosed with graft versus host disease and was treated with Proleukin (View Usage). After Proleukin was administered, patient had the following side effects: haemophilus sepsis, pain (What is pain?), thrombocytopenia. Proleukin dosage: 0.3 X 10^6 Iu/m^2/d Daily; Route Used 057. During the same period patient was treated with ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), BIAXIN (View Biaxin Review and Biaxin Label ), DECADRON ELIXIR (View Decadron Elixir Review and Decadron Elixir Label ), POTASSIUM LOTREL (View Potassium Lotrel Review and Potassium Lotrel Label ), MEPRON (View Mepron Review and Mepron Label ), VITAMIN CAP (View Vitamin Cap Review and Vitamin Cap Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), SIROLIMUS (View Sirolimus Review and Sirolimus Label ). Patient was hospitalized.

5588172-7 | Chills, Diarrhoea, Eye Swelling, Pharyngeal Oedema, Rash Erythematous, Rash Pruritic, Swollen Tongue, Tachycardia
on Jan 09, 2008 Male patient from UNITED STATES , weighting 180.9 lb, was treated with Proleukin (View Usage). Patient experienced the following unwanted or unexpected effects: chills, diarrhoea, eye swelling, pharyngeal oedema, rash erythematous, rash pruritic, swollen tongue, tachycardia. Proleukin dosage: .

5489526-X | Blood Creatinine Increased, Blood Urea Increased, Hypercalcaemia
Patient was taking Proleukin (View Usage). Patient had the following side effects: blood creatinine increased, blood urea increased, hypercalcaemia on Oct 16, 2007 from UNITED STATES Additional patient health information: Male patient , 44 years of age, weighting 148.0 lb, was diagnosed with metastatic renal cell carcinoma and. Proleukin dosage: 600,000 International Q8hrs/d 1-5, 15-19 Iv. During the same period patient was treated with ATIVAN (View Ativan Review and Ativan Label ), ZANTAC (View Zantac Review and Zantac Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), BENADRYL (View Benadryl Review and Benadryl Label ), COMPAZINE (View Compazine Review and Compazine Label ), LOMOTIL (View Lomotil Review and Lomotil Label ), SARNA LOTION (View Sarna Lotion Review and Sarna Lotion Label ), EUCERIN LOTION (View Eucerin Lotion Review and Eucerin Lotion Label ). Patient was hospitalized.

5483734-X | Pancreatitis Acute
Adverse event was reported on Oct 09, 2007 by a Male patient taking Proleukin (View Usage) (Dosage: 55.5 Mu Iv Q 8 Hours) . Location: UNITED STATES , weighting 204.0 lb, After Proleukin was administered, patient had the following side effects: pancreatitis acute. During the same period patient was treated with AVASTIN (940 Mg Iv Q 2 Weeks) (View Avastin Review and Avastin Label ), CADUET (View Caduet Review and Caduet Label ), AMBIEN (View Ambien Review and Ambien Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), LORTAB (View Lortab Review and Lortab Label ), ATIVAN (View Ativan Review and Ativan Label ), VICODIN (View Vicodin Review and Vicodin Label ), ZOLOFT (View Zoloft Review and Zoloft Label ). Patient was hospitalized.

5367090-3 | Dyspnoea
on Jun 19, 2007 Male patient from UNITED STATES , weighting 207.2 lb, was treated with Proleukin (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea. Proleukin dosage: 11.8 Miu Sq M-f X6wks. Patient was hospitalized.

5361598-2 | Apnoea, Arrhythmia, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Blood Creatinine Increased, Blood Glucose Increased, Blood Potassium Decreased, Blood Urea Increased
on Jun 12, 2007 Male patient from UNITED STATES , 61 years of age, weighting 241.4 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Proleukin (View Usage). Patient had the following side effects: apnoea, arrhythmia (What is arrhythmia?), aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood glucose increased, blood potassium decreased, blood urea increased. Proleukin dosage: 600,000 Iu/kg. During the same period patient was treated with SUTENT (Three Cycles) (View Sutent Review and Sutent Label ).

5345209-8 | Abdominal Distension, Anuria, Bladder Distension, Blood Calcium Decreased, Blood Creatinine Increased, Blood Parathyroid Hormone Decreased, Blood Parathyroid Hormone Increased, Blood Potassium Increased, Blood Urea Increased
Patient was taking Proleukin (View Usage). After Proleukin was administered, patient had the following side effects: abdominal distension, anuria, bladder distension, blood calcium decreased, blood creatinine increased, blood parathyroid hormone decreased, blood parathyroid hormone increased, blood potassium increased, blood urea increased on May 24, 2007 from UNITED STATES Additional patient health information: Male patient , 76 years of age, . Proleukin dosage: . During the same period patient was treated with NEXIUM (40 Mg, Qd) (View Nexium Review and Nexium Label ), CARDURA (4 Mg, Qd) (View Cardura Review and Cardura Label ), LOTREL (10/40 Mg Qd) (View Lotrel Review and Lotrel Label ), ATENOLOL (100 Mg, Qd) (View Atenolol Review and Atenolol Label ), CALTRATE (View Caltrate Review and Caltrate Label ), IRON (View Iron Review and Iron Label ). Patient was hospitalized.

5336760-5 | Hypophosphataemia, Lymphopenia
Adverse event was reported on May 17, 2007 by a Male patient taking Proleukin (View Usage) (Dosage: 720000 Iu/kg 1/8 Hr) was diagnosed with metastatic malignant melanoma and. Location: UNITED STATES , 51 years of age, Patient experienced the following unwanted or unexpected effects: hypophosphataemia, lymphopenia. Patient was hospitalized.

5334791-2 | Blood Creatinine Increased, Dyspnoea, Hypophosphataemia, Lymphopenia, Mental Status Changes
on May 17, 2007 Male patient from UNITED STATES , 47 years of age, was diagnosed with metastatic malignant melanoma and was treated with Proleukin (View Usage). Patient had the following side effects: blood creatinine increased, dyspnoea, hypophosphataemia, lymphopenia, mental status changes. Proleukin dosage: 720000 Iu/kg 1/8 Hr. During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), LOTENSIN (View Lotensin Review and Lotensin Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), SYNTHROID (View Synthroid Review and Synthroid Label ).

5325909-6 | Abdominal Pain, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Aspiration Pleural Cavity, Bilirubin Conjugated Increased, Blood Albumin Decreased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Blood Calcium Decreased
on May 04, 2007 Female patient from UNITED STATES , 50 years of age, was treated with Proleukin (View Usage). After Proleukin was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), alanine aminotransferase increased, aspartate aminotransferase increased, aspiration pleural cavity, bilirubin conjugated increased, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood calcium decreased. Proleukin dosage: 32 Million Iu. During the same period patient was treated with BEVACIZUMAB (535 Mg) (View Bevacizumab Review and Bevacizumab Label ), ALDESLEUKIN (View Aldesleukin Review and Aldesleukin Label ). Patient was hospitalized.

5317565-8 | Cardiac Failure Congestive, Catheterisation Cardiac Abnormal, Dyspnoea, Ejection Fraction Decreased, Left Ventricular End-diastolic Pressure Increased, Myocardial Infarction, Myocardial Ischaemia, Nausea, Pneumonia
Patient was taking Proleukin (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure congestive, catheterisation cardiac abnormal, dyspnoea, ejection fraction decreased, left ventricular end-diastolic pressure increased, myocardial infarction, myocardial ischaemia, nausea (What is nausea?), pneumonia (What is pneumonia?) on Apr 29, 2007 from UNITED STATES Additional patient health information: Female patient , 50 years of age, . Proleukin dosage: . During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ). Patient was hospitalized.

5304472-X | Benign Prostatic Hyperplasia, Dehydration, Diarrhoea, Disease Progression, Urine Output Decreased
Adverse event was reported on Apr 19, 2007 by a Male patient taking Proleukin (View Usage) (Dosage: 720,000 Iu Iv) was diagnosed with malignant melanoma and. Location: UNITED STATES , 62 years of age, Patient had the following side effects: benign prostatic hyperplasia, dehydration, diarrhoea, disease progression, urine output decreased. During the same period patient was treated with ACIPHEX (View Aciphex Review and Aciphex Label ), AMBIEN (View Ambien Review and Ambien Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ). Patient was hospitalized.

5289495-1 | Anaemia, Anuria, Blood Creatinine Increased, Erythroblastosis, Hypotension, Hypoxia, Leukocytosis, Megakaryocytes Abnormal, Metabolic Acidosis
on Mar 23, 2007 Female patient from SPAIN , 35 years of age, was diagnosed with renal cell carcinoma stage iv and was treated with Proleukin (View Usage). After Proleukin was administered, patient had the following side effects: anaemia, anuria, blood creatinine increased, erythroblastosis, hypotension, hypoxia, leukocytosis, megakaryocytes abnormal, metabolic acidosis. Proleukin dosage: 600,000 U/kg Every 8h For 5 Days. Patient was hospitalized.

5289495-1 | Anaemia, Anuria, Blood Creatinine Increased, Erythroblastosis, Hypotension, Hypoxia, Leukocytosis, Megakaryocytes Abnormal, Metabolic Acidosis
on Mar 23, 2007 Female patient from SPAIN , 35 years of age, was diagnosed with renal cell carcinoma stage iv and was treated with Proleukin (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, anuria, blood creatinine increased, erythroblastosis, hypotension, hypoxia, leukocytosis, megakaryocytes abnormal, metabolic acidosis. Proleukin dosage: 600,000 U/kg Every 8h For 5 Days. Patient was hospitalized.

5282924-9 | Cough, Influenza Like Illness, Pruritus, Pyrexia, Urticaria
Patient was taking Proleukin (View Usage). Patient had the following side effects: cough, influenza like illness, pruritus, pyrexia, urticaria on Mar 19, 2007 from Additional patient health information: Female patient , 44 years of age, weighting 121.3 lb, was diagnosed with hiv infection (What is hiv infection?) and. Proleukin dosage: 6 Miu, Unk. During the same period patient was treated with EMTRIVA (View Emtriva Review and Emtriva Label ), VIDEX (View Videx Review and Videx Label ), SUSTIVA (View Sustiva Review and Sustiva Label ), PROZAC (View Prozac Review and Prozac Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), ATARAX (View Atarax Review and Atarax Label ). Patient was hospitalized.